Retour
50
17
Également cotée sous
SNPHY
OTC
Fourchette du Jour
10,99 €
10,99 €
Fourchette 52 Semaines
8,88 €
11,45 €
Volume
2 000
Moyenne 50J / 200J
9,69 €
/
10,54 €
Clôture Précédente
10,99 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,1 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 12,2 | 3,7 |
| Net Margin % | 12,1 | 3,9 |
| Rev Growth 5Y % | 4,7 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
177,59 €
161,40 € – 185,56 €
|
390 B | 1 |
| FY2029 |
166,99 €
151,77 € – 174,49 €
|
370 B | 1 |
| FY2028 |
134,13 €
121,91 € – 140,15 €
|
310 B | 1 |
Points Clés
Revenue grew 4,71% annually over 5 years — modest growth
Earnings grew 36,09% over the past year
ROE of 12,24% — decent returns on equity
Debt/Equity of 0,12 — conservative balance sheet
Generating 54,27B in free cash flow
P/E of 0,10 — trading at a low valuation
Croissance
Revenue Growth (5Y)
4,71%
Revenue (1Y)-0,65%
Earnings (1Y)36,09%
FCF Growth (3Y)107,87%
Qualité
Return on Equity
12,24%
ROIC10,97%
Net Margin12,09%
Op. Margin15,63%
Sécurité
Debt / Equity
0,12
Current Ratio2,58
Interest Coverage17,26
Valorisation
P/E Ratio
0,10
P/B Ratio0,01
EV/EBITDA-1,18
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,65% | Revenue Growth (3Y) | 3,69% |
| Earnings Growth (1Y) | 36,09% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4,71% | Earnings Growth (5Y) | 51,79% |
| Profitability | |||
| Revenue (TTM) | 300,00B | Net Income (TTM) | 36,26B |
| ROE | 12,24% | ROA | 8,86% |
| Gross Margin | 57,01% | Operating Margin | 15,63% |
| Net Margin | 12,09% | Free Cash Flow (TTM) | 54,27B |
| ROIC | 10,97% | FCF Growth (3Y) | 107,87% |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 2,58 |
| Interest Coverage | 17,26 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 0,10 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | 0,35 |
| EV/EBITDA | -1,18 | Dividend Yield | 0,02% |
| Market Cap | 3,54B | Enterprise Value | -55,23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 300,00B | 301,97B | 279,04B | 266,26B | 249,61B |
| Net Income | 36,26B | 26,64B | -14,95B | 27,22B | 6,83B |
| EPS (Diluted) | 103,68 | 72,37 | -38,58 | 67,97 | 17,06 |
| Gross Profit | 171,03B | 178,71B | 166,09B | 156,59B | 151,38B |
| Operating Income | 46,88B | 38,54B | -3,09B | 35,89B | 37,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 409,28B | 435,70B | 421,18B | 459,98B | 402,35B |
| Total Liabilities | 124,10B | 130,33B | 127,88B | 123,13B | 95,30B |
| Shareholders' Equity | 286,24B | 306,06B | 293,98B | 337,49B | 307,59B |
| Total Debt | 34,23B | 35,16B | 36,21B | 32,93B | 10,15B |
| Cash & Equivalents | 93,00B | 94,58B | 57,90B | 83,01B | 62,89B |
| Current Assets | 224,30B | 236,14B | 213,33B | 229,43B | 206,23B |
| Current Liabilities | 86,84B | 92,80B | 89,50B | 95,82B | 78,55B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#293 of 820
#506 of 708
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026